By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
I agree
Search Trends
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
An illustration from the published study shows how the new immunotherapy works. /ACS Nano
Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano.
In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article.
The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, Lu added.
Researchers from the School of Life Sciences of Tianjin University conduct an experiment at a laboratory in north China's Tianjin Municipality, March 15, 2024. /Xinhua
Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Cover: An illustration of cancer cells. /CFP)